TSQ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TSQ is not a good buy right now for an impatient investor. The stock has only a mild/fragile technical upswing, but fundamentals are deteriorating (Q3 2025 revenue down, losses widened), insiders are aggressively selling, and Wall Street is cutting price targets despite keeping Outperform ratings. With no Intellectia buy signals today and mixed options sentiment, the risk/reward does not justify buying immediately at ~6.57.
Price/Trend: TSQ is up ~2% in the regular session and sits around 6.57 post-market, slightly above the 6.318 pivot—marginally constructive but not a clear breakout. Momentum: MACD histogram is positive (0.0902) but contracting, implying bullish momentum is weakening rather than accelerating. RSI: RSI(6) ~62.9 (neutral-to-slightly warm), not oversold—so there is no “must-buy” dip signal for an impatient entry. Moving averages: Converging MAs suggest consolidation/indecision rather than a strong trend. Key levels: Support S1 ~5.519 (then S2 ~5.026). Resistance R1 ~7.116 (then R2 ~7.609). The stock is closer to pivot than resistance, so upside requires a clean push through ~7.12. Pattern-based short-term odds: Similar-pattern stats suggest a 50% chance of ~-3.42% next day and ~-0.88% over the next week, which is not ideal for buying immediately without a confirmed breakout.
Intellectia Proprietary Trading Signals
Management presentation at Noble Capital Markets Emerging Growth Virtual Equity Conference on Feb 4, 2026; (
Q4 2025 earnings release and conference call on Mar 16,
These can spark volatility and narrative changes if results/guidance surprise positively. Analysts also still carry Outperform ratings, suggesting some belief in longer-term upside (particularly digital segments).
Insider activity is a key negative: insiders are selling and the selling amount increased ~169% over the last month.
Operational headwinds: Analysts explicitly cite continued traffic-related challenges in the programmatic business and lowered expectations following Q3 results/updated Q4 guidance.
Near-term technical risk: Pattern-based stats skew slightly negative for next day/week, and MACD momentum is weakening (positive but contracting).
Latest quarter: 2025/Q3. Growth/profitability trend: Revenue fell to ~$106.76M (-7.42% YoY). Net income dropped to about -$5.90M (worse by -154.41% YoY), with EPS at -0.36 (-157.14% YoY). Gross margin slipped to ~21.88% (-5.03% YoY). Takeaway: The company is showing negative growth and worsening profitability in the latest reported quarter, which undermines the case for an impatient buy unless a clear turnaround catalyst is imminent.
Recent trend: Analysts kept Outperform ratings but cut price targets materially.
